Loading...

A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcom a of the uterus, an NRG Oncology/Gynecologic Oncology Group study()

BACKGROUND: The primary objectives were to determine the objective response rate (ORR) and safety profile of ixabepilone in women with recurrent or persistent uterine carcinosarcoma (UCS). Secondary objectives included progression-free survival (PFS) and overall survival (OS). Exploratory translatio...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Gynecol Oncol
Main Authors: McCourt, Carolyn K., Deng, Wei, Dizon, Don S., Lankes, Heather A., Birrer, Michael J., Lomme, Michele M., Powell, Matthew A., Kendrick, James E., Saltzman, Joel N., Warshal, David, Tenney, Meaghan E., Kushner, David M., Aghajanian, Carol
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362250/
https://ncbi.nlm.nih.gov/pubmed/28029447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.10.026
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!